Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC)

NCT00034957 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung
Lung Neoplasms

Interventions

DRUG: Investigational drug

Sponsor

Pfizer